Cempra, Inc. to Present at Piper Jaffray 25th Annual

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cempra, Inc. to Present at Piper Jaffray 25th Annual Healthcare Conference and Oppenheimer 24th Annual Healthcare Conference

CHAPEL HILL, N.C., Dec. 2, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq: CEMP ) today announced that Prabhavathi Fernandes, Ph.D., chief executive officer of Cempra, will present at the Piper Jaffray 25 th Annual Healthcare Conference at 2:30 p.m. EST, Wednesday, Dec. 4, at The New York Palace Hotel, and at the Oppenheimer 24 th Annual Healthcare Conference at 3:55 p.m. EST, Wednesday, Dec. 11, at The Crowne Plaza Hotel in New York City. Dr. Fernandes will discuss the company's two differentiated antibiotics, solithromycin (CEM-101) for community-acquired bacterial pneumonia and TAKSTA (CEM-102 or fusidic acid) for the chronic, oral treatment of Gram-positive pathogens including methicillin-resistant S. aureus (MRSA) in prosthetic joint infections.

About Cempra, Inc.

Founded in 2006, Cempra, Inc. is a late clinical-stage pharmaceutical company focused on developing antibiotics to treat critical bacterial infections in patients in both acute and primary care settings. Cempra's two lead product candidates are currently in advanced clinical development. Solithromycin (CEM-101) is in two Phase 3 clinical trial for community-acquired bacterial pneumonia (CABP) and is licensed to strategic commercial partner Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings Corporation, for certain exclusive rights in Japan. TAKSTA™ (CEM-102) is Cempra's second product candidate currently in a Phase 2 clinical trial for prosthetic joint infections. TAKSTA was recently granted orphan drug designation for this indication. Both product candidates seek to address the need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. The company also intends to use its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about Cempra can be found at www.cempra.com .

Please Note : This press release contains forward-looking statements regarding future events. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others: the results, timing, costs and regulatory review of our studies and clinical trials; the results of studies of our product candidates conducted by others; our need to obtain additional funding and our ability to obtain future funding on acceptable terms; our anticipated capital expenditures and our estimates regarding our capital requirements; our ability to obtain FDA approval of our product candidates; our dependence on the success of solithromycin and Taksta; the possible impairment of, or inability to obtain, intellectual property rights and the costs of obtaining such rights from third parties; and innovation by our competitors. The reader is referred to the documents that we file from time to time with the Securities and Exchange Commission.

Investor and Media Contacts: Robert E. Flamm, Ph.D. Russo Partners, LLC (212) 845-4226 Andreas Marathovouniotis Russo Partners, LLC (212) 845-4235

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Endava's Stock Tumble Sparks Investor Class Action

Updated Category News Views 2

A Rocky Day for Endava Investors Here's the thing, on September 21, 2026, Endava plc hit a rough patch that left a mark. After the market closed, the company announced that it had put its Chief Financial Officer, Mark Thurston, on administrative leave. This wasn't just a routine shuffle; it came on the heels of the Board's Audit Committee finding reason to probe into...

Continue Reading
CorePower Yoga Expands in Miami with New Studios

Updated Category News Views 9

Greasing the Wheels of Miami's Wellness Scene If you're living under a rock, you might not have noticed, but CorePower Yoga is making some serious moves in Miami. We're talking about two new studios opening their doors: one in Midtown Miami, already rolling out the mats as of October 19, and another flagship joint soon to hit Coral Gables. Clearly, they see the demand for...

Continue Reading
Geothermal Energy Gets Boost with GRMS Adoption

Updated Category News Views 4

Geothermal's Big Leap with the GRMS The oil and gas sector didn't explode overnight—it leapt due to a consistent, standardized language that spoke to investors like a charm. Now, the geothermal industry is borrowing a page from this book of success with the Geothermal Resources Management System (GRMS). Finally, a framework not just built on hope and hot air, but...

Continue Reading
Call to Action: Make Disease Cure the Top Election Issue

Updated Category News Views 3

A Call for Congressional Accountability The American Center for Cures is banging the drum for change, and they're banging it loud. Founded by Lou Weisbach, this group has come out swinging, urging Americans to slap disease onto the ballot in the midterms. Why? Because dealing with Alzheimer's, diabetes, heart disease, and cancer every year rips a whopping $1.1 trillion...

Continue Reading
Norwegian Bella™: A New Era in Luxury Cruising

Updated Category News Views 5

Setting Sail with Norwegian Bella™ in 2028 When you hear about another cruise ship hitting the water, eye rolls might come naturally. But Norwegian Cruise Line's latest announcement adds a few twists worth noting. Today, the big news is that the Norwegian Bella™, the freshest face in NCL's innovative Prima Class, is now open for bookings. This beauty will start its...

Continue Reading
NSSF Battles NM's Unconstitutional Gun Law in Court

Updated Category News Views 6

Taking Shots at New Mexico's Gun Laws You've got the National Shooting Sports Foundation (NSSF) heading back into the legal trenches. Fresh lawsuit filed, they're targeting New Mexico's Attorney General, Raúl Torrez, for trying to keep a seven-day "cooling off" period intact that they've already been told is unconstitutional. Look, this ain't their first rodeo with this...

Continue Reading
Zika Virus: A Surprising Ally in Brain Cancer Fight

Updated Category News Views 9

Here’s something you don’t hear every day: using a virus that typically targets the brain not as a foe, but as a formidable ally in the war against glioblastoma. It’s a gutsy play by UP Oncolytics, a scrappy biotech outfit cradled within Rosalind Franklin University’s Helix 51 incubator. Risky Bet on a Known Adversary Glioblastoma—a real beast in the cancer...

Continue Reading
AI Agents Race: 10M Downloads Spark Competitive Fire

Updated Category News Views 4

The AI Agent Arms Race is On Throwdown time in the AI jungle, folks. A new AI agent hit the big 10.9 million downloads in a mere six weeks. In the digital world, those kinds of numbers are the equivalent of finding a unicorn in your backyard. This data gem comes courtesy of Sensor Tower, as reported by Yahoo Finance, and it looks like the appetite for this technological...

Continue Reading
Parents as Teachers Podcast: Anthem Awards Finalist

Updated Category News Views 4

Celebrating Impact Through Parenthood Narratives Blending heartfelt stories with educational insights, the Parents as Teachers Podcast stands tall as a Finalist in two categories of the 6th Annual Anthem Awards. Recognizing achievements in Content & Media for both Education, Art & Culture and Health, this nod acknowledges the profound impact being made on family...

Continue Reading
PrecisePK Celebrates 40 Years of Revolution in Dosing

Updated Category News Views 1

Forty Years of Changing the Game There’s something to be said for sticking around in an industry for four decades. PrecisePK, a name that's become synonymous with precision dosing, has been revolutionizing how pharmacists do their jobs since 1985. This isn’t just a company resting on its laurels; it’s at the forefront of technological integration in healthcare....

Continue Reading

Top 5 Most Recently Viewed Articles

Transmute and mesur.io Unite to Transform Global Supply Chain Management

Updated Category News Views 373

Transmute and mesur.io Unite for Supply Chain Enhancement In a strategic development set to reshape global trade dynamics, Transmute and mesur.io have combined forces to address the increasing complexities of supply chains. Their primary mission is to mitigate disruptions and risks associated with international commerce. This combination is geared towards fostering a more...

Continue Reading
Transforming $1000 Into $2831 in OR Royalties: A Five-Year Journey

Updated Category News Views 122

Introduction to OR Royalties' Market Performance OR Royalties (NYSE: OR) has made a remarkable impact on investors' portfolios over the last five years. With an impressive annualized return of 23.69%, it has exceeded market expectations by 10.18%, showcasing the company's strong market capitalization of $6.10 billion. Investment Growth Over Five Years If an investor had...

Continue Reading
Drut Technologies Launches Innovative 2500 Series for AI Infrastructure

Updated Category News Views 238

Transforming Data Centers with Drut Technologies' 2500 Series Drut Technologies Inc., a prominent name in photonic data center solutions, is making waves with the introduction of their groundbreaking 2500 product series. This new suite of products is designed to revolutionize data center infrastructure, elevating efficiency, reconfigurability, and performance to...

Continue Reading
SentiLink Hires Kathleen Waid: A Game-Changer for Growth

Updated Category News Views 252

Waid’s Experience Sets the Stage for Growth Here’s the lowdown: SentiLink just snagged Kathleen Waid as their Chief Revenue Officer. That's a solid move, no two ways about it. We're talking about a seasoned pro here, with over 20 years under her belt in scaling fraud prevention and identity verification companies. Now, as the name of the game is increasingly rooted in...

Continue Reading
Pulsecare Medical's NxPFA™ Redefining Atrial Fibrillation Treatment

Updated Category News Views 180

Introducing NxPFA™: A New Era in Atrial Fibrillation Treatment Pulsecare Medical has set itself apart in the realm of cardiovascular intervention with its groundbreaking NxPFA™ system. This revolutionary device is recognized as the world's first nanosecond pulsed field ablation (ns-PFA) system, having achieved marketing approval from China's National Medical Products...

Continue Reading